Verici Dx (AIM: VRCI), a developer of advanced clinical diagnostics for organ transplant, announces that its testing laboratory in Franklin, TN, has been accredited by the internationally recognised College of American Pathology (CAP) following the completion of an on-site audit. The Company, whose clinical laboratory is already CLIA certified, voluntarily sought the accreditation as part of its on-going commitment to maintaining best in class quality systems. CAP accreditation is a hallmark of quality and excellence in clinical laboratory services and adds to the Company’s existing portfolio of quality assurance awards and recognition.
In achieving the CAP accreditation requirements, which often exceed the standards from CLIA, FDA and OSHA, Verici Dx exhibits focus on excellence in patient care and laboratory safety. It also further demonstrates the laboratory’s ability to deliver reliable and accurate test results to support patient clinical management.
Patti Connolly, Chief Operating Officer at Verici Dx, said: “We are pleased that our highly skilled laboratory team
successfully achieved this accreditation with no deficiencies, findings, or recommendations identified during the
audit. This accomplishment affirms our commitment to operating at the highest standards that healthcare
providers, patients, and regulatory bodies expect."